Cargando…

Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting

BACKGROUND: Colorectal cancer-specific biomarkers have been used as molecular targets for fluorescent intra-operative imaging, targeted PET/MRI, and selective cytotoxic drug delivery yet the selection of biomarkers used is rarely evidence-based. We evaluated sensitivities and specificites of four of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tiernan, J P, Perry, S L, Verghese, E T, West, N P, Yeluri, S, Jayne, D G, Hughes, T A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593555/ https://www.ncbi.nlm.nih.gov/pubmed/23322207 http://dx.doi.org/10.1038/bjc.2012.605

Ejemplares similares

Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells
por: Madhok, B M, et al.
Publicado: (2010)

Humanised IgG1 antibody variants targeting membrane-bound carcinoembryonic antigen by antibody-dependent cellular cytotoxicity and phagocytosis
por: Ashraf, S Q, et al.
Publicado: (2009)

Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinoma
por: Kobayashi, M, et al.
Publicado: (2012)

Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancer
por: Greystoke, A, et al.
Publicado: (2012)

The influence of invasive growth pattern and microvessel density on prognosis in colorectal cancer and colorectal liver metastases
por: Rajaganeshan, R, et al.
Publicado: (2007)

Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer
por: Letellier, E, et al.
Publicado: (2014)

KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer
por: Renaud, S, et al.
Publicado: (2015)

The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients
por: West, N P, et al.
Publicado: (2010)

Disseminated tumour cells as a prognostic biomarker in colorectal cancer
por: Flatmark, K, et al.
Publicado: (2011)

Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer
por: Zanutto, S, et al.
Publicado: (2014)

Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis
por: Carter, Jane V, et al.
Publicado: (2017)

MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer
por: Ng, E K O, et al.
Publicado: (2009)

Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma
por: Zheng, G, et al.
Publicado: (2014)

Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using In Vitro and In Vivo Models
por: Pramanik, Arindam, et al.
Publicado: (2022)

MiR-320e is a novel prognostic biomarker in colorectal cancer
por: Perez-Carbonell, L, et al.
Publicado: (2015)

Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer
por: Matsumura, T, et al.
Publicado: (2015)

Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer
por: Yuan, Zixu, et al.
Publicado: (2017)

Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancer
por: Kim, J C, et al.
Publicado: (2013)

Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma
por: Lièvre, Astrid, et al.
Publicado: (2017)

Expression of pEGFR and pAKT as response-predictive biomarkers for RAS wild-type patients to anti-EGFR monoclonal antibodies in metastatic colorectal cancers
por: Harlé, A, et al.
Publicado: (2015)

Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma
por: Greystoke, A, et al.
Publicado: (2011)

FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role
por: Bullock, M D, et al.
Publicado: (2013)

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases
por: Goos, J A C M, et al.
Publicado: (2014)

microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma
por: Yau, T O, et al.
Publicado: (2014)

MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1
por: Feng, Y, et al.
Publicado: (2014)

Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT–PCR
por: Ohlsson, L, et al.
Publicado: (2006)

Smad7 induces hepatic metastasis in colorectal cancer
por: Halder, S K, et al.
Publicado: (2008)

Detailed analysis of inflammatory cell infiltration in colorectal cancer
por: Väyrynen, J P, et al.
Publicado: (2013)

Distinct expression pattern of the full set of secreted phospholipases A(2) in human colorectal adenocarcinomas: sPLA(2)-III as a biomarker candidate
por: Mounier, C M, et al.
Publicado: (2008)

Are there biological differences between screen-detected and interval colorectal cancers in the English Bowel Cancer Screening Programme?
por: Walsh, Elizabeth, et al.
Publicado: (2016)

Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab
por: Fuchs, Charles S, et al.
Publicado: (2016)

Radiation-induced non-targeted response in vivo: role of the TGFβ-TGFBR1-COX-2 signalling pathway
por: Chai, Y, et al.
Publicado: (2013)

The in situ local immune response, tumour senescence and proliferation in colorectal cancer
por: Roxburgh, C S, et al.
Publicado: (2013)

EMAP-II-dependent lymphocyte killing is associated with hypoxia in colorectal cancer
por: Youssef, M M S, et al.
Publicado: (2006)

Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer
por: Pichler, M, et al.
Publicado: (2012)

Molecular determination of epidermal growth factor receptor in normal and neoplastic colorectal mucosa
por: Piazzi, G, et al.
Publicado: (2006)

Serum biomarker panels for the diagnosis of gastric adenocarcinoma
por: Ahn, H S, et al.
Publicado: (2012)

Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
por: Chua, W, et al.
Publicado: (2009)

Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma
por: Kantola, T, et al.
Publicado: (2012)

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
por: Talieri, M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_12uli226ntd7n8umsf40d7j4f2